Historical record - last NADAC publication: 8/23/2023
Product Information
LEVETIRACETAM ER 750 MG TABLET is a generic product labeled by Omnivium Pharmaceuticals LLC, priced at $0.3160 per EA under NDC 81665010060. Its NADAC has been published 37 times since Dec 21, 2022.
The High Outlier badge above means this manufacturer's average price in the LEVETIRACETAM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/1
Manufacturer
Omnivium Pharmaceuticals LLCNDC
81665010060
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA212688On Market Since
6/11/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM ER 750 MG TABLET has been published 37 times since Dec 21, 2022, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3160 per EA |
|---|---|
| All-time high | $0.3491 (Apr 12, 2023) |
| All-time low | $0.2644 (Jun 21, 2023) |
| Median price | $0.3153 |
| Average price | $0.3071 |
| Largest weekly change | +16.8% (Aug 23, 2023) |
| Weeks tracked | 37 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM ER 750 MG TABLET, manufactured by Omnivium Pharmaceuticals LLC, is $0.3160 per EA (NDC 81665010060), effective Aug 30, 2023.
How has the price of LEVETIRACETAM ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM ER 750 MG TABLET has risen 4.5%. It has been tracked across 37 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM ER 750 MG TABLET?
Since Dec 21, 2022, the NADAC for LEVETIRACETAM ER 750 MG TABLET has ranged from a low of $0.2644 (Jun 21, 2023) to a high of $0.3491 (Apr 12, 2023), with a median of $0.3153 per EA.
Are there cheaper alternatives to LEVETIRACETAM ER 750 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM ER 750 MG TABLET, is $0.2253 per EA — about 29% below LEVETIRACETAM ER 750 MG TABLET.
Who manufactures LEVETIRACETAM ER 750 MG TABLET?
LEVETIRACETAM ER 750 MG TABLET (NDC 81665010060) is labeled by Omnivium Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification